Quest Diagnostics reaffirmed as a buy: organic growth, macro demand, strong margins, investment-grade ratings, and dividend ...

Quest Diagnostics DGX is set to release its third-quarter 2025 results on Oct. 21, before the market opens. The renowned diagnostics provider posted adjusted earnings per share (EPS) of $2.62 in the ...

Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that it has been named to the Fortune® magazine 2026 World's Most Admired Companies™ list, for the ...

Quest Diagnostics may be the preferred lab your health insurance, doctors, or specialists use for blood work or other samples. We’re reviewing its sub-brand Quest Health, from which you can order your ...

July 22 (Reuters) - Laboratory operator Quest Diagnostics (DGX.N), opens new tab raised its 2025 profit and revenue forecasts on Tuesday, banking on robust demand for its diagnostic tests, sending the ...

President and CEO Jim Davis said he believes PAMA reform will pass this year but said another temporary delay will likely be needed to postpone cuts slated for February 1.

Detailed price information for Quest Diagnostics Inc (DGX-N) from The Globe and Mail including charting and trades.